The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects von Hurchla, M A, Garcia-Gomez, A, Hornick, M C, Ocio, E M, Li, A, Blanco, J F, Collins, L, Kirk, C J, Piwnica-Worms, D, Vij, R, Tomasson, M H, Pandiella, A, San Miguel, J F, Garayoa, M, Weilbaecher, K N

Volltext

The skinny on obesity and plasma cell myeloma: a review of the literature von Carson, K R, Bates, M L, Tomasson, M H

Volltext

Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study von Uy, G L, Goyal, S D, Fisher, N M, Oza, A Y, Tomasson, M H, Stockerl-Goldstein, K, DiPersio, J F, Vij, R

Volltext

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma von Hao, M, Franqui-Machin, R, Xu, H, Shaughnessy, J, Barlogie, B, Roodman, D, Quelle, D E, Janz, S, Tomasson, M H, Sanderson, R D, Qiu, L, Frech, I, Tricot, G, Zhan, F

Volltext

P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B‐CELL MATURATION ANTIGEN (BCMA)‐CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR... von Lesokhin, A. M., Arnulf, B., Niesvizky, R., Mohty, M., Bahlis, N. J., Tomasson, M. H., Rodrίguez‐Otero, P., Quach, H., Raje, N. S., Iida, S., Raab, M.‐S., Czibere, A., Sullivan, S., Leip, E., Viqueira, A., Leleu, X.

Volltext

An Activated Receptor Tyrosine Kinase, TEL/PDGFβR, Cooperates with AML1/ETO to Induce Acute Myeloid Leukemia in Mice von Grisolano, Jay L., O'Neal, Julie, Cain, Jennifer, Tomasson, Michael H.

Volltext

A Murine Model of CML Blast Crisis Induced by Cooperation between BCR/ABL and NUP98/HOXA9 von Dash, Ajeeta B., Williams, Ifor R., Kutok, Jeffery L., Tomasson, Michael H., Anastasiadou, Ema, Lindahl, Kathleen, Li, Shaoguang, Van Etten, Richard A., Borrow, Julian, Housman, David, Druker, Brian, Gilliland, D. Gary

Volltext

EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA von Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM

Volltext

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2... von Schwaller, Juerg, Frantsve, Julie, Aster, Jon, Williams, Ifor R., Tomasson, Michael H., Ross, Theodora S., Peeters, Pieter, Van Rompaey, Luc, Van Etten, Richard A., Ilaria Jr, Robert, Marynen, Peter, Gilliland, D.Gary

Volltext

The TEL/Platelet-Derived Growth Factor β Receptor (PDGFβ R) Fusion in Chronic Myelomonocytic Leukemia is a Transforming Protein that Self-Associates and Activates PDGFβ R Kinase-De... von Carroll, Martin, Tomasson, Michael H., Barker, George F., Golub, Todd R., Gilliland, D. Gary

Volltext

Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia von Xiang, Zhifu, Luo, Hui, Payton, Jacqueline E, Cain, Jennifer, Ley, Timothy J, Opferman, Joseph T, Tomasson, Michael H

Volltext

Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3 von Tomasson, Michael H., Williams, Ifor R., Li, Shaoguang, Kutok, Jeffrey, Cain, Danielle, Gillessen, Silke, Dranoff, Glenn, Van Etten, Richard A., Gilliland, D. Gary

Volltext

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL von Li, Shaoguang, Gillessen, Silke, Tomasson, Michael H., Dranoff, Glenn, Gilliland, D. Gary, Van Etten, Richard A.

Volltext

Intrinsic Human Immunodeficiency Virus Type 1 Resistance of Hematopoietic Stem Cells Despite Coreceptor Expression von Shen, H, Cheng, T, Preffer, F I, Dombkowski, D, Tomasson, M H, Golan, D E, Yang, O, Hofmann, W, Sodroski, J G, Luster, A D, Scadden, D T

Volltext

c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations von Luo, Hui, Li, Qing, O'Neal, Julie, Kreisel, Friederike, Le Beau, Michelle M., Tomasson, Michael H.

Volltext

A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM): INITIAL SAFETY R... von Lesokhin, AM, Arnulf, B, Niesvizky, R, Mohty, M, Bahlis, NJ, Tomasson, MH, Rodrguez-Otero, P, Quach, H, Raje, NS, Iida, S, Raab, M, Czibere, A, Sullivan, S, Leip, E, Viqueira, A, Blunk, V, Leleu, X

Volltext

TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor von TOMASSON, M. H, WILLIAMS, I. R, HASSERJIAN, R, UDOMSAKDI, C, MCGRATH, S. M, SCHWALLER, J, DRUKER, B, GILLILAND, D. G

Volltext

A prospective study of the effects of once weekly bortezomib on markers of bone metabolism in patients with multiple myeloma (MM) von Peles, S., Fisher, N. M., Gao, F., Tomasson, M. H., Dipersio, J. F., Vij, R.

Volltext

Bortezomib Inhibits Osteoclast Activity in Patients with Multiple Myeloma von Uy, Geoffrey L., Trivedi, Rachna, Peles, Shachar, Fisher, Nicholas M., Zhang, Qin (Jean), Tomasson, Michael H., DiPersio, John F., Vij, Ravi

Volltext

Fatal myeloproliferation, induced in mice by TEL/PDGFβR expression, depends on PDGFβR tyrosines 579/581 von Tomasson, Michael H., Sternberg, David W., Williams, Ifor R., Carroll, Martin, Cain, Danielle, Aster, Jon C., Ilaria, Robert L., Etten, Richard A. Van, Gilliland, D. Gary

Volltext